Organisation paid for research Program year 2024 Source: CMS Open Payments

Allcutis Research

Neither a doctor nor a teaching hospital

Research payments

$233,719

33 payments

Through program year 2024, Allcutis Research is reported as receiving $233,719 in research payments, across 33 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$14,243	5
2023	Research	$77,130	11
2022	Research	$117,301	15
2021	Research	$8,012	1
2020	Research	$17,033	1

Breakdown

Who paid Research payments · program years 2020–2024

Almirall LLC $141,757 20 payments
E.R. Squibb & Sons, L.L.C. $89,116 11 payments
Amgen Inc. $2,845 2 payments

Studies the money was for Research payments · program years 2020–2024

M14867-32 $141,757 20 payments
A Phase 3B/4, Multicenter, Randomized, Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Moderate-to-severe Scalp Psoriasis (PSORIATYK SCALP) $42,349 5 payments
Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis $40,842 5 payments
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease $5,925 1 payment
ASTRO P3 AD Adolescent Mono $2,845 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.